Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5696702 | 0.88 | — | — | |
| SCHEMBL7214781 | 0.78 | SMN1; SMN2 (0.45) | ALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL9224609 | 0.76 | — | — | |
| SCHEMBL1710249 | 0.76 | ALDH1A1 (0.37) | ALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL4029442 | 0.76 | LMNA (0.48) | ALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL7059111 | 0.76 | LMNA (0.48) | ALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL1710460 | 0.71 | ALDH1A1 (0.47) | ALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL1710365 | 0.69 | — | — | |
| SCHEMBL8402688 | 0.69 | — | — | |
| Ethylene Glycol SCHEMBL10615430 | 0.69 | TSHR (0.33) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116535672-B | Preparation method and application of hyperbranched modified enzymatic hydrolysis lignin epoxy resin | 山西生物质新材料产业研究院有限公司 | 2024-11-22 | — | — | CN | claimed |
| CN-117402372-A | Preparation method of medium-temperature curing flame-retardant lignin-based curing agent | 上海汉禾生物新材料科技有限公司 | 2024-01-16 | — | — | CN | claimed |
| CN-117343282-A | Preparation method and application of flame-retardant lignin-based epoxy resin | 上海汉禾生物新材料科技有限公司 | 2024-01-05 | — | — | CN | claimed |
| CN-116535672-A | Preparation method and application of hyperbranched modified enzymatic hydrolysis lignin epoxy resin | 山西生物质新材料产业研究院有限公司 | 2023-08-04 | — | — | CN | claimed |
| CN-102197055-A | Curable composition for transfer material and pattern formation method | SHOWA DENKO KK | 2011-09-21 | — | — | CN | claimed |
| US-20110206834-A1 | CURABLE COMPOSITION FOR TRANSFER MATERIALS, AND PATTERN FORMING PROCESS | SHOWA DENKO K.K. (JP) | 2011-08-25 | — | — | US | claimed |
| EP-2345676-A1 | CURABLE COMPOSITION FOR TRANSFER MATERIAL AND PATTERN FORMATION METHOD | SHOWA DENKO K.K. (JP) | 2011-07-20 | — | — | EP | claimed |
| US-20260085078-A1 | NON-AQUEOUS SYNTHESIS OF SILYLCARBONATE SOLVENTS | UCHICAGO ARGONNE, LLC (US) | 2026-03-26 | — | — | US | disclosed |
| CN-116535672-B | Preparation method and application of hyperbranched modified enzymatic hydrolysis lignin epoxy resin | 山西生物质新材料产业研究院有限公司 | 2024-11-22 | — | — | CN | disclosed |
| EP-4371982-A2 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | RQX Pharmaceuticals, Inc. (US) | 2024-05-22 | — | — | EP | disclosed |
| EP-3583096-B1 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | RQX PHARMACEUTICALS INC (US) | 2024-03-27 | — | — | EP | disclosed |
| CN-117402372-A | Preparation method of medium-temperature curing flame-retardant lignin-based curing agent | 上海汉禾生物新材料科技有限公司 | 2024-01-16 | — | — | CN | disclosed |
| CN-117343282-A | Preparation method and application of flame-retardant lignin-based epoxy resin | 上海汉禾生物新材料科技有限公司 | 2024-01-05 | — | — | CN | disclosed |
| WO-1995018616-A2 | 8-AZA, 6-AZA AND 6,8-DIAZA-1,4-DIHYDROQUINOXALINE-2,3-DIONES AND THE USE THEREOF AS ANTAGONISTS FOR THE GLYCINE/NMDA RECEPTOR | ACEA PHARM INC (US) | 1995-07-13 | — | — | WO | disclosed |
| EP-0642523-A1 | GANGLIOSIDE ANALOGS. | SYMBICOM AB (SE) | 1995-03-15 | — | — | EP | disclosed |
| WO-1995005378-A1 | ANTIVIRAL THIAZOLES | PFIZER INC. (US) | 1995-02-23 | — | — | WO | disclosed |
| US-5380835-A | Chemically phosphorylating the 5'-hydroxyl terminus of an oligonucleotide | ABBOTT LABORATORIES (US) | 1995-01-10 | — | — | US | disclosed |
| WO-1994027605-A1 | 1,2,3,4-TETRAHYDROQUINOLINE-2,3,4-TRIONE-3 OR 4-OXIMES AND USE | STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON, EUGENE, OREGON (US) | 1994-12-08 | — | — | WO | disclosed |
| US-5159095-A | Reagant for phosphorylating oligonucleotides | ABBOTT LABORATORIES (US) | 1992-10-27 | — | — | US | disclosed |
| US-5113005-A | Hydrosilation | ABBOTT LABORATORIES (US) | 1992-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260085078-A1 | NON-AQUEOUS SYNTHESIS OF SILYLCARBONATE SOLVENTS | TRPV2, TRPV3, TRPM2 | ALDH1A1 3475/4885TSHR 4110/4885SMN1; SMN2 771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.